69.00
—
Close of 9 Nov 2026, in ZAc
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Afrocentric Investment Corporation
Its shares trade on JSE under the ticker ACT.JO. It has been listed since 17 May 2006. In the fiscal year to 31 December 2024, it reported a net loss of ZAR 125.9m. At that date it held total assets of ZAR 5.16bn and shareholders' equity of ZAR 3.25bn.
AfroCentric Investment Corp. Ltd. operates as an investment holding company. The company is headquartered in Roodepoort, Gauteng. The company went IPO on 2006-05-17. The firm's segments include Healthcare SA, Healthcare Retail, Healthcare Africa and Information Technology (IT). The Healthcare SA segment consists of medical scheme administration and health risk management services, including Medscheme. The Healthcare Retail segment consists of pharmaceutical sales/services by Pharmacy Direct, Scriptpharm Risk Management, Curasana Wholesaler, Activo Health and Activo Healthcare Assets Group. The Healthcare Africa segment consists of all healthcare services outside of South Africa (Namibia and Mauritius). The IT segment relates to all IT-related services for the Company within South Africa. The firm's subsidiaries include ACT Healthcare Assets Proprietary Limited and ACT Funding Proprietary Limited.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Financials
- Industry
- Financial Services
- Listed since
- 17 May 2006
- Employees
- 5,503
- Website
- afrocentric.za.com ↗
Leadership
Pay as last reported
- Dr. Anna MokgokongNon-Executive Chairman of the Board, since 2010ZAR 725,000
- Mr. Gerald Van WykGroup Chief Executive Officer, Executive Director, since 2023
- Mr. M. Joe MadungandabaDeputy Chairman of the Board, since 2010
- Mr. Hannes BoonzaaierGroup Chief Financial Officer, Executive Director, since 2015
- Mr. Aklaaq MahmoodExecutive Director
- Mr. Billy MokaleGroup Company Secretary
- Mr. J. Bruno FernandesLead Independent Non-Executive Director
- Mr. Gary AllenNon-Executive Director
- Mr. Thinus Alsworth-elveyNon-Executive Director
- Ms. Marinda DippenaarNon-Executive Director
- Mr. Paul HanrattyNon-Executive Director
- Ms. Karabo MoruleNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Afrocentric Investment Corporation Ltd employs 5,503 full-time employees in the Financials sector.
- Healthcare SA segment includes Medscheme for medical scheme administration services.
- Healthcare Retail segment features Pharmacy Direct and Scriptpharm for pharmaceutical services.
Weaknesses
- Healthcare Africa segment operates in Namibia and Mauritius with limited market presence.
- IT segment focuses solely on South Africa without international expansion.
- Financials sector exposure to South African economic volatility.
Opportunities
- Healthcare Africa segment can expand into new African markets beyond Namibia and Mauritius.
- IT segment can leverage South Africa's growing Information Technology sector.
- Healthcare Retail segment can increase market share through Pharmacy Direct and Scriptpharm.
Threats
- Healthcare SA segment faces competition from established medical schemes in South Africa.
- Financials sector is vulnerable to regulatory changes in South Africa.
- Healthcare Africa segment risks political instability in Namibia and Mauritius.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.